Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JPAD Trial: Aspirin for Primary Prevention of Atherosclerosis in Type 2 Diabetes
NCT00110448Phase 4Completed
- Sponsor
- Kumamoto University
- Start
- Dec 2002
- Primary completion
- Apr 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin in atherosclerosis, cardiovascular disease (CVD), cerebrovascular disease, sponsored by Kumamoto University. Started Dec 2002; status: completed.
02
Drugs
aspirin
03
Conditions
atherosclerosiscardiovascular disease (CVD)cerebrovascular disease
Beyond the preview
Go deeper on NCT00110448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00110448.